

A Canadian neurologist whose pioneering research unlocked critical insights into Parkinson's disease and Friedreich's ataxia.
Dr. André Barbeau was a towering figure in Canadian neurology, whose meticulous research brought new understanding to some of medicine's most complex neurodegenerative disorders. Born in 1931 in Quebec, he built his career at the University of Montreal, where his clinical work was matched by a relentless drive for discovery. In the 1960s and 70s, his investigations into the role of the neurotransmitter dopamine were fundamental in shaping the modern biochemical understanding of Parkinson's disease, directly informing treatment strategies. He also made seminal contributions to the study of Friedreich's ataxia, a genetic condition, helping to define its clinical and genetic patterns. Barbeau's curiosity extended to exploring amino acids like taurine in neurological function. His legacy is not just in his publications but in the generations of neurologists he trained and the patients whose lives were improved by his dedicated pursuit of answers.
1928–1945
Born between the Depression and the end of WWII. Too young to fight, old enough to remember. They became the conformist middle managers of the 1950s — and the civil rights leaders who quietly dismantled Jim Crow.
André was born in 1931, placing them squarely in The Silent Generation. The events that shaped this generation — world wars, depression, and rapid industrialization — shaped the world they entered and the choices available to them.
The biggest hits of 1931
#1 Movie
Frankenstein
Best Picture
Cimarron
The world at every milestone
The Empire State Building opens as the world's tallest
Jesse Owens wins four golds at the Berlin Olympics
D-Day: Allied forces land at Normandy
India gains independence; the Dead Sea Scrolls found
NATO founded; Mao proclaims the People's Republic of China
Queen Elizabeth II ascends the throne
Yuri Gagarin becomes the first human in space
Voting age lowered to 18 in the US
MTV launches; first Space Shuttle flight; AIDS identified
Challenger disaster; Chernobyl nuclear meltdown
He was a French-Canadian researcher who published extensively in both French and English.
His work extended to studying the potential neurological effects of the amino acid taurine.
The 'Barbeau Award' is named in his honor by the Canadian Congress of Neurological Sciences.
“To understand the disease, you must first listen carefully to what the patient cannot say.”